McKesson Prescription Technology Solutions president Nathan Mott said the company has created a broad and deep network throughout the continuum of care.
Alembic has received the FDA ok for generic Vigamox, and Tricore, which have a market value of $68 million, and $92 million, respectively, for the 12 months ending December 2018.
Meijer launched the Consumer Drug Take-Back Program in all its locations by installing kiosks where consumers can properly dispose of unused or expired prescriptions.
At the 20th DSN Industry Issues Summit, panelists discussed the challenges pharmacies face include measuring outcomes, getting payers on board, connecting better with providers, and even further engaging patients.
